Mannatech, Inc. Hits New 52-Week Low at USD 3.92

Mannatech, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 3.92 on May 21, 2026. This significant decline highlights the company's ongoing struggles, as it has experienced a substantial 44.75% drop in its stock price over the past year, contrasting sharply with the S&P 500's performance of 27.39% during the same period. The company's financial metrics reveal a challenging landscape. Mannatech has reported a net profit of -USD 2.39 million, reflecting a dramatic decline of 150.84%. Additionally, the company's cash and equivalents have reached a low of USD 13.77 million, raising concerns about its liquidity position. With a debt-to-equity ratio of -0.40 and a return on equity of -23.83%, the financial health of Mannatech appears precarious. Institutional investors have also reduced their stakes in the company by 10.19% in the previous quarter, now holding only 12.16% of the firm. This trend, combined with the company's underperformance relative to broader market indices, underscores the difficulties Mannatech faces in regaining stability and investor confidence.